Dr. Christopher Roger Miller , MD
Urology โข Lancaster, PA
2106 Harrisburg Pike Ste 200
Lancaster, PA 176012644
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 15, 2013; this date does not establish years in practice.
-
Published CMS data list 5,436 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q9967 โ Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 2,625 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 557 service units.
- 99214 โ Established patient outpatient office visit: 380 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 27 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 2,391 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Finasteride โ 733 prescription fills, including refills.
- Alfuzosin Hcl Er (Alfuzosin Hcl) โ 539 prescription fills, including refills.
- Tamsulosin Hcl โ 514 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 19 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Urology in Pennsylvania (2024, 390 clinicians with data). Median for this group: 1,096. Middle half: 513 to 2,950.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,080 in 2020 to 5,436 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
2106 Harrisburg Pike Ste 200
Lancaster, PA 176012644
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: The Centers For Advanced Urology Llp. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Temple University School Of Medicine
2013
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
779 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $170,727 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $123,860 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
6,113 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$147,657 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $634.75 across 32 records.
By nature of payment
- Food and Beverage: $634.75 across 32 records.
Reporting-company totals (3 largest of 14)
- Astellas Pharma US Inc: $185.34 across 11 records.
- ABBVIE INC.: $110.96 across 5 records.
- Pfizer Inc.: $55.88 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
13 years (graduated 2013)
CMS Doctors and Clinicians data list 2013 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2013
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Miller has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Miller as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Lancaster and Pennsylvania
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Urology in Pennsylvania (2024, 390 clinicians with data). Median for this group: 1,096. Middle half: 513 to 2,950.
Too few clinicians listed under Urology in Lancaster have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Urology in Pennsylvania (2024, 390 clinicians with data). Median for this group: $94,510. Middle half: $45,936 to $184,918.
Too few clinicians listed under Urology in Lancaster have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Urology in Pennsylvania (2024, 390 clinicians with data). Median for this group: $69,281. Middle half: $34,043 to $137,962.
Too few clinicians listed under Urology in Lancaster have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Urology in Pennsylvania (2024, 448 clinicians with data). Median for this group: 889. Middle half: 232 to 2,017.
Too few clinicians listed under Urology in Lancaster have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 60% of clinicians listed under Urology in Pennsylvania (2024, 448 clinicians with data). Median for this group: $72,128. Middle half: $10,730 to $241,715.
Too few clinicians listed under Urology in Lancaster have Medicare Part D data for 2024 to compare.
19 active clinicians are listed under Urology with a practice address in Lancaster, PA (664 in Pennsylvania).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Lancaster
5.3% of these 19 clinicians have the CMS telehealth indicator.
47.4% of these 19 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 76% from 3,080 in 2020 to 5,436 in 2024.
- 2020: 3,080
- 2021: 5,105
- 2022: 3,754
- 2023: 5,171
- 2024: 5,436
-
Medicare-allowed amount
Medicare-allowed amount increased 50% from $113,505 in 2020 to $170,727 in 2024.
- 2020: $113,505
- 2021: $133,818
- 2022: $156,604
- 2023: $172,250
- 2024: $170,727
-
Paid by Medicare
Paid by Medicare increased 47% from $84,028 in 2020 to $123,860 in 2024.
- 2020: $84,028
- 2021: $97,980
- 2022: $112,618
- 2023: $129,276
- 2024: $123,860
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 70% from 1,408 in 2020 to 2,391 in 2024.
- 2020: 1,408
- 2021: 1,522
- 2022: 1,957
- 2023: 2,347
- 2024: 2,391
-
30-day fills
30-day fills increased 92% from 3,176 in 2020 to 6,113 in 2024.
- 2020: 3,176
- 2021: 3,444
- 2022: 4,813
- 2023: 5,812
- 2024: 6,113
-
Part D drug cost
Part D drug cost increased 64% from $90,288 in 2020 to $147,657 in 2024.
- 2020: $90,288
- 2021: $92,475
- 2022: $108,086
- 2023: $145,883
- 2024: $147,657
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 96% from $15,433.24 in 2021 to $634.75 in 2025.
- 2021: $15,433.24
- 2022: $782.62
- 2023: $670.43
- 2024: $755.45
- 2025: $634.75
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 32 records totaling $634.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $28.88 |
| Olympus America Inc. |
Food and Beverage
In-kind items and services
|
iTIND System | General | $28.53 |
| UROGEN PHARMA, INC. |
Food and Beverage
In-kind items and services
|
JELMYTO | General | $27.59 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $26.29 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $24.28 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $24.18 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $23.28 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $22.72 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $21.11 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
BOTOX | General | $20.87 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $20.71 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $20.54 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $19.35 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Nubeqa | General | $19.25 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $19.22 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $19.07 |
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
ADSTILADRIN | General | $18.85 |
| Ethicon Inc. |
Food and Beverage
In-kind items and services
|
MONOCRYL | General | $18.59 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $18.38 |
| Laborie Medical Technologies Corp. |
Food and Beverage
Cash or cash equivalent
|
Optilume BPH Drug Coated Balloon Catheter | General | $18.26 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
KEYTRUDA | General | $18.17 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $17.77 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $17.46 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $17.46 |
| Astellas Pharma US Inc |
Food and Beverage
In-kind items and services
|
Xtandi | General | $17.34 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2017โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2018โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
2,625 | 23 | $3.00 | $0.13 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
557 | 388 | $25.00 | $15.63 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
380 | 276 | $210.00 | $121.05 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
340 | 284 | $139.00 | $84.98 |
|
81003
Automated urinalysis test
|
326 | 255 | $15.00 | $2.20 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
223 | 189 | $41.00 | $10.31 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
219 | 193 | $20.00 | $3.10 |
|
76770
Complete ultrasound scan behind abdominal cavity
|
130 | 122 | $316.00 | $100.20 |
|
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
|
76 | 64 | $86.21 | $46.86 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
72 | 63 | $585.00 | $75.77 |
|
99221
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
|
65 | 64 | $201.00 | $78.44 |
|
74420
Imaging of urinary tract following injection of a contrast agent
|
57 | 53 | $260.00 | $22.62 |
|
52356
Crushing of stone of ureter with insertion of stent using an endoscope
|
50 | 50 | $1298.60 | $393.04 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
45 | 45 | $323.00 | $158.54 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
41 | 41 | $210.00 | $105.52 |
|
51741
Electronic assessment of bladder emptying
|
34 | 33 | $209.00 | $10.68 |
|
36415
Insertion of needle into vein for collection of blood sample
|
26 | 25 | $16.92 | $8.65 |
|
76872
Ultrasound scan of pelvic region through rectum
|
22 | 22 | $327.00 | $123.05 |
|
51728
Complex measurement of pressure of urine flow in bladder with voiding pressure studies
|
20 | 20 | $594.00 | $336.07 |
|
51784
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings
|
20 | 18 | $559.00 | $34.70 |
|
51797
Insertion of device into abdomen with pressure and urine flow rate study
|
20 | 20 | $419.00 | $173.93 |
|
74178
Ct scan of abdomen and pelvis before and after contrast
|
20 | 20 | $800.00 | $232.02 |
|
51702
Simple insertion of temporary bladder tube
|
19 | 14 | $240.00 | $56.18 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
14 | 14 | $281.00 | $123.68 |
|
76872
Ultrasound scan of pelvic region through rectum
|
12 | 12 | $327.00 | $30.76 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Finasteride | Finasteride | 733 | 63,242 | $9,524.16 | 255 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 539 | 45,994 | $12,849.86 | 188 |
| Tamsulosin Hcl | Tamsulosin Hcl | 514 | 40,577 | $8,120.55 | 181 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 140 | 9,113 | $2,659.94 | 74 |
| Myrbetriq | Mirabegron | 119 | 6,400 | $94,281.64 | 38 |
| Levofloxacin | Levofloxacin | 59 | 178 | $109.86 | 50 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 56 | 960 | $201.34 | 47 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | 142 | $120.07 | 51 |
| Dutasteride | Dutasteride | 36 | 3,240 | $1,946.59 | 11 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 19 | 483 | $837.30 | 12 |
| Methenamine Hippurate | Methenamine Hippurate | 19 | 859 | $921.04 | โ |
| Potassium Citrate Er | Potassium Citrate | 17 | 1,530 | $2,391.66 | โ |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 16 | 607 | $1,671.08 | โ |
| Terazosin Hcl | Terazosin Hcl | 13 | 1,170 | $172.31 | โ |
| Solifenacin Succinate | Solifenacin Succinate | 13 | 1,110 | $979.86 | โ |
| Dutasteride-Tamsulosin | Dutasteride/Tamsulosin Hcl | 12 | 360 | $835.92 | โ |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | 990 | $183.42 | โ |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 11 | 96 | $110.96 | โ |
| Gemtesa | Vibegron | 11 | 630 | $9,739.30 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-12-21NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20180514002556
PA
2567768807
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
The Centers For Advanced Urology Llp
400 Davis Dr, Plymouth Meeting, PA 194621718
Phone: 6108252151
The Centers For Advanced Urology Llp
211 S Gulph Rd, King Of Prussia, PA 194063101
Phone: 6105793577
The Centers For Advanced Urology Llp
2106 Harrisburg Pike, Lancaster, PA 176012644
Phone: 7173931771
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Urology
Doctor of Medicine (M.D.)
Nurse Practitioner
Certified Registered Nurse Practitioner
Physician Assistant
Physician Assistant
Nurse Practitioner - Family
Certified Registered Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Urology (license number reported to NPPES: PA MT204065)
Registered at 2106 HARRISBURG PIKE STE 200, LANCASTER, PA 176012644 (Tel: 7173931771)
Registered at 2106 HARRISBURG PIKE STE 200, LANCASTER, PA 176012644 (Tel: 7173931771)
Recorded as CHRISTOPHER MILLER, M.D.
Urology (license number reported to NPPES: PA MD463898)
NPI status registered as active in NPPES database
Registered at 3400 SPRUCE ST, PHILADELPHIA, PA 191044206 (Tel: 2153495042)
Registered at 3400 SPRUCE ST, PHILADELPHIA, PA 191044206 (Tel: 2153495042)
Recorded as CHRISTOPHER MILLER, MD
Urology (license number reported to NPPES: PA MT204065)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Lancaster
- Dr. Russell Hayden, MD
- Dr. Geoffrey Gaunay, MD
- Dr. Kenneth Lessans, MD
- Dr. Paul Sieber, MD
- Dr. Mark Jarowenko, MD
- Dr. Paul Russinko, MD
Mailing Address
2106 Harrisburg Pike Ste 200
Lancaster, PA 176012644
Phone: 7173931771